Results 241 to 250 of about 94,345 (348)
Unveiling the Genetic Association Between Hemoglobin Concentration and Amyotrophic Lateral Sclerosis
This study identified a causal relationship between genetically predicted hemoglobin (Hb) concentration and amyotrophic lateral sclerosis (ALS) through Mendelian randomization (MR), and integrated RNA‐seq and RT‐qPCR analyses to highlight BACH1, FLVCR1, and TRIM58 as potential genes involved in this association.
Hongmei Luo +4 more
wiley +1 more source
Residual Genetic Material in Mature Red Blood Cells. [PDF]
Dryllis G +10 more
europepmc +1 more source
The debate in the field of cancer immunotherapy is being changed as nanotechnology breaks the obstacle of cancer immune evasion, target delivery, and systemic toxicity. Esthetically advanced methods that are discussed in this review are nanovaccine, nanoparticle‐enabled checkpoint barrier, cytokine delivery, and T‐cell modulation techniques that ...
Daniel Ejim Uti +7 more
wiley +1 more source
Monge's disease at 100 years: Revisiting the origins and endocrine mechanisms of chronic mountain sickness. [PDF]
Gonzales GF.
europepmc +1 more source
Anaesthesia, Volume 81, Issue 2, Page 291-293, February 2026.
Hee Won Choi +3 more
wiley +1 more source
Tofacitinib Use in a Patient With Rheumatoid Arthritis and Polycythemia Vera: A Case Report
ABSTRACT Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial inflammation and joint destruction, whereas polycythemia vera (PV) is a myeloproliferative neoplasm driven by the Janus kinase (JAK)2 V617F mutation, resulting in erythrocytosis and increased thromboembolic risk.
Milan Bogojevic +4 more
wiley +1 more source
Novel agents and evolving strategies for anemia management in lower-risk myelodysplastic syndromes. [PDF]
Hong J.
europepmc +1 more source
Outline of Iron Metabolism, with Emphasis on Erythroid Cells. [PDF]
Testa U, Pelosi E, Castelli G.
europepmc +1 more source
Abstract Fibrodysplasia ossificans progressiva is a rare, progressive autosomal dominant genetic disease caused by an activin receptor‐like kinase 2 (ALK2) mutation with a need for effective prophylactic therapies. This single‐center, randomized, double‐blind, placebo‐controlled study evaluated the pharmacokinetics and safety of DS‐6016a, a novel ...
Kei Okita +9 more
wiley +1 more source
Inhibition of XPO1 by selinexor enhances terminal erythroid maturation through modulation of HSP70 trafficking in severe β0-thalassemia/HbE. [PDF]
Khamphikham P +2 more
europepmc +1 more source

